← Leaderboards
Rajan P Adhikari
Integrated Biotherapeutics, Inc.
$2,976,940
Attributed
$5,349,271
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2012–21$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$5,349,271 · 5
By mechanism
R42$2,963,566 · 1
R43$1,790,774 · 3
R41$594,931 · 1
Top collaborators
- Ramin M. Hakami6 shared
- Daniel C. Nelson6 shared
Most similar at Integrated Biotherapeutics, Inc.
Same institution · by research overlap
- Ramin M. Hakami$1,186,166
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelProteinsIn VivoVaccinesPathogenBacteriaInfectionAntibioticsToxinAntibodiesTechnologySiteNew TechnologyNational Institute Of Allergy And Infectious DiseaseCellsNeutrophilBaseSurfaceIn VitroNovel StrategiesSkinBindingLinkAntigens
Grant awards (12)
Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis$663,271
R42 · FY2021 · AI · contact PI
Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis$315,000
R42 · FY2021 · AI · contact PI
Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis$985,298
R42 · FY2020 · AI · contact PI
ISTAb- A novel therapy to target staphylococcal toxins at the site of infections$300,000
R43 · FY2020 · AI · contact PI
Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis$999,997
R42 · FY2019 · AI · contact PI
ISTAb- A novel therapy to target staphylococcal toxins at the site of infections$300,000
R43 · FY2019 · AI · contact PI
Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis$299,999
R41 · FY2018 · AI · contact PI
Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis$294,932
R41 · FY2017 · AI · contact PI
In vivo conjugated multivalent toxoid-polysaccharide vaccine for S. aureus$299,996
R43 · FY2015 · AI · contact PI
In vivo conjugated multivalent toxoid-polysaccharide vaccine for S. aureus$300,000
R43 · FY2014 · AI · contact PI
A novel Structure Based Vaccine for staphylococcal alpha hemolysin$290,778
R43 · FY2013 · AI · contact PI
A novel Structure Based Vaccine for staphylococcal alpha hemolysin$300,000
R43 · FY2012 · AI · contact PI